1. Home
  2. CHMI vs CMRX Comparison

CHMI vs CMRX Comparison

Compare CHMI & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • CMRX
  • Stock Information
  • Founded
  • CHMI 2012
  • CMRX 2000
  • Country
  • CHMI United States
  • CMRX United States
  • Employees
  • CHMI N/A
  • CMRX N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • CMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • CMRX Health Care
  • Exchange
  • CHMI Nasdaq
  • CMRX Nasdaq
  • Market Cap
  • CHMI 87.0M
  • CMRX 77.1M
  • IPO Year
  • CHMI 2013
  • CMRX 2013
  • Fundamental
  • Price
  • CHMI $2.59
  • CMRX $2.79
  • Analyst Decision
  • CHMI Buy
  • CMRX Strong Buy
  • Analyst Count
  • CHMI 2
  • CMRX 2
  • Target Price
  • CHMI $5.00
  • CMRX $8.50
  • AVG Volume (30 Days)
  • CHMI 267.0K
  • CMRX 11.2M
  • Earning Date
  • CHMI 11-12-2024
  • CMRX 11-07-2024
  • Dividend Yield
  • CHMI 23.03%
  • CMRX N/A
  • EPS Growth
  • CHMI N/A
  • CMRX N/A
  • EPS
  • CHMI N/A
  • CMRX N/A
  • Revenue
  • CHMI N/A
  • CMRX $159,000.00
  • Revenue This Year
  • CHMI N/A
  • CMRX N/A
  • Revenue Next Year
  • CHMI $12.15
  • CMRX $1,690.28
  • P/E Ratio
  • CHMI N/A
  • CMRX N/A
  • Revenue Growth
  • CHMI N/A
  • CMRX N/A
  • 52 Week Low
  • CHMI $2.50
  • CMRX $0.75
  • 52 Week High
  • CHMI $4.39
  • CMRX $3.39
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 33.84
  • CMRX 84.35
  • Support Level
  • CHMI $2.60
  • CMRX $2.74
  • Resistance Level
  • CHMI $2.74
  • CMRX $3.02
  • Average True Range (ATR)
  • CHMI 0.06
  • CMRX 0.26
  • MACD
  • CHMI 0.02
  • CMRX 0.18
  • Stochastic Oscillator
  • CHMI 5.54
  • CMRX 77.13

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Share on Social Networks: